Ovarian cancer solid adenocarcinoma. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Cell Line, Tumor Tumor Cells, Cultured Cardia Esophagogastric Junction Ovary Neoplastic Stem Cells Epithelial Cells Prostate Epithelium Ampulla of Vater Cell Line HT29 Cells

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases65

Adenocarcinoma Ovarian Neoplasms Neoplasms, Glandular and Epithelial Adenocarcinoma, Mucinous Lung Neoplasms Pancreatic Neoplasms Cystadenocarcinoma, Serous Stomach Neoplasms Esophageal Neoplasms Adenocarcinoma, Papillary Colonic Neoplasms Neoplasm Invasiveness Adenocarcinoma, Clear Cell Breast Neoplasms Carcinoma Carcinoma, Endometrioid Carcinoma, Pancreatic Ductal Prostatic Neoplasms Neoplasm Metastasis Barrett Esophagus Adenocarcinoma, Bronchiolo-Alveolar Endometrial Neoplasms Neoplasms Peritoneal Neoplasms Disease Progression Carcinoma, Squamous Cell Genetic Predisposition to Disease Ascites Neoplasm Recurrence, Local Cystadenocarcinoma Colorectal Neoplasms Uterine Cervical Neoplasms Neoplasms, Multiple Primary Carcinoma, Non-Small-Cell Lung Precancerous Conditions Rectal Neoplasms Cell Transformation, Neoplastic Fallopian Tube Neoplasms Mammary Neoplasms, Experimental Neoplasms, Cystic, Mucinous, and Serous Cystadenocarcinoma, Mucinous Neovascularization, Pathologic Genital Neoplasms, Female Intestinal Neoplasms Adenoma Neoplasms, Experimental Gastrointestinal Neoplasms Urinary Bladder Neoplasms Neoplastic Syndromes, Hereditary Carcinoma, Small Cell Carcinoma, Signet Ring Cell Liver Neoplasms Carcinoma in Situ Hereditary Breast and Ovarian Cancer Syndrome Cystadenoma, Serous Metaplasia Disease Models, Animal Cecal Neoplasms Duodenal Neoplasms Neoplasms, Second Primary Uterine Neoplasms Carcinoma, Adenosquamous Common Bile Duct Neoplasms Cystadenocarcinoma, Papillary Carcinoma, Acinar Cell

Chemicals and Drugs62

CA-125 Antigen Tumor Markers, Biological Antineoplastic Agents Neoplasm Proteins Cisplatin Paclitaxel BRCA2 Protein DNA, Neoplasm RNA, Messenger BRCA1 Protein Antineoplastic Agents, Phytogenic Antigens, Neoplasm Tumor Suppressor Protein p53 Carboplatin RNA, Small Interfering Epididymal Secretory Proteins Receptor, Epidermal Growth Factor Cancer Vaccines Antibodies, Monoclonal Receptor, erbB-2 Deoxycytidine RNA, Neoplasm Antigens, Tumor-Associated, Carbohydrate Fluorouracil Keratin-7 Carcinoembryonic Antigen Platinum Receptors, Estrogen Platinum Compounds Transcription Factors Proto-Oncogene Proteins Antimetabolites, Antineoplastic Tumor Suppressor Proteins Mucin-1 Organoplatinum Compounds Taxoids DNA-Binding Proteins MicroRNAs Nuclear Proteins Topotecan ras Proteins Proto-Oncogene Proteins c-akt Quinazolines Receptors, Progesterone Prostate-Specific Antigen Ki-67 Antigen Membrane Proteins GPI-Linked Proteins Anticarcinogenic Agents Protein Kinase Inhibitors Cadherins DNA Primers Antibodies, Neoplasm Antibodies, Monoclonal, Humanized Tamoxifen Keratin-20 Cyclooxygenase 2 Carcinogens beta Catenin Mucins Vascular Endothelial Growth Factor A Contraceptives, Oral

Analytical, Diagnostic and Therapeutic Techniques and Equipment65

Neoplasm Staging Prognosis Early Detection of Cancer Immunohistochemistry Survival Analysis Antineoplastic Combined Chemotherapy Protocols Survival Rate Reverse Transcriptase Polymerase Chain Reaction Xenograft Model Antitumor Assays Gene Expression Profiling Neoplasm Transplantation Retrospective Studies Disease-Free Survival Risk Factors Tissue Array Analysis Blotting, Western Kaplan-Meier Estimate Treatment Outcome Follow-Up Studies Transplantation, Heterologous Immunoenzyme Techniques Combined Modality Therapy Oligonucleotide Array Sequence Analysis Risk Sensitivity and Specificity Prospective Studies Polymerase Chain Reaction Case-Control Studies Mammary Neoplasms, Experimental Drug Screening Assays, Antitumor Odds Ratio Risk Assessment Multivariate Analysis Tumor Burden Neoplasm Grading Chemotherapy, Adjuvant DNA Mutational Analysis Registries Genetic Testing Predictive Value of Tests Drug Administration Schedule Transfection Incidence Neoplasms, Experimental Biopsy Reproducibility of Results Flow Cytometry Cohort Studies SEER Program Molecular Targeted Therapy Gene Knockdown Techniques Disease Models, Animal Gastrectomy Logistic Models Tomography, X-Ray Computed Clinical Trials as Topic Confidence Intervals Questionnaires Models, Biological In Situ Hybridization, Fluorescence Enzyme-Linked Immunosorbent Assay Hysterectomy Salpingectomy Genetic Therapy Biopsy, Needle

Psychiatry and Psychology1

Phenomena and Processes44

Gene Expression Regulation, Neoplastic Genes, BRCA1 Drug Resistance, Neoplasm Genes, BRCA2 Mutation Cell Proliferation Genetic Predisposition to Disease Apoptosis Germ-Line Mutation Risk Sensitivity and Specificity DNA Methylation Cell Survival Cell Division Signal Transduction Dose-Response Relationship, Drug Odds Ratio Up-Regulation Cell Movement Genes, Tumor Suppressor Down-Regulation Time Factors Cell Growth Processes Genotype Genes, ras Transfection Cell Cycle Promoter Regions, Genetic Loss of Heterozygosity Gene Silencing Gene Expression Base Sequence RNA Interference Genes, p53 Polymorphism, Genetic Genes, Neoplasm Drug Synergism Gene Amplification Heterozygote Phenotype Alleles Phosphorylation Tumor Microenvironment Epithelial-Mesenchymal Transition

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Information Science7

Survival Rate Registries Incidence Base Sequence Molecular Sequence Data SEER Program Questionnaires

Named Groups2

Health Care28

Survival Analysis Survival Rate Retrospective Studies Disease-Free Survival Risk Factors Kaplan-Meier Estimate Treatment Outcome Follow-Up Studies Risk Sensitivity and Specificity Prospective Studies Case-Control Studies Odds Ratio Risk Assessment Multivariate Analysis Registries Genetic Testing Predictive Value of Tests Age Factors Incidence Reproducibility of Results Cohort Studies SEER Program Logistic Models Clinical Trials as Topic Confidence Intervals National Cancer Institute (U.S.)Questionnaires

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Information Science Health Care Geographicals

Adenocarcinoma Ovarian Neoplasms Neoplasms, Glandular and Epithelial Adenocarcinoma, Mucinous Lung Neoplasms Cell Line, Tumor Pancreatic Neoplasms CA-125 Antigen Cystadenocarcinoma, Serous Stomach Neoplasms Tumor Markers, Biological Gene Expression Regulation, Neoplastic Esophageal Neoplasms Adenocarcinoma, Papillary Neoplasm Staging Prognosis Colonic Neoplasms Antineoplastic Agents Early Detection of Cancer Neoplasm Invasiveness Genes, BRCA1 Adenocarcinoma, Clear Cell Mice, Nude Immunohistochemistry Breast Neoplasms Carcinoma Carcinoma, Endometrioid Carcinoma, Pancreatic Ductal Prostatic Neoplasms Drug Resistance, Neoplasm Neoplasm Proteins Cisplatin Neoplasm Metastasis Barrett Esophagus Tumor Cells, Cultured Adenocarcinoma, Bronchiolo-Alveolar Survival Analysis Endometrial Neoplasms Neoplasms Paclitaxel Antineoplastic Combined Chemotherapy Protocols Survival Rate Reverse Transcriptase Polymerase Chain Reaction Genes, BRCA2 Peritoneal Neoplasms Disease Progression Mutation Carcinoma, Squamous Cell Xenograft Model Antitumor Assays Gene Expression Profiling BRCA2 Protein Cardia Neoplasm Transplantation Cell Proliferation DNA, Neoplasm RNA, Messenger Genetic Predisposition to Disease Retrospective Studies BRCA1 Protein Ascites Neoplasm Recurrence, Local Cystadenocarcinoma Colorectal Neoplasms Apoptosis Disease-Free Survival Antineoplastic Agents, Phytogenic Risk Factors Tissue Array Analysis Antigens, Neoplasm Blotting, Western Uterine Cervical Neoplasms Neoplasms, Multiple Primary Tumor Suppressor Protein p53 Carcinoma, Non-Small-Cell Lung Kaplan-Meier Estimate Treatment Outcome Follow-Up Studies Precancerous Conditions Carboplatin Transplantation, Heterologous Immunoenzyme Techniques Combined Modality Therapy Rectal Neoplasms Germ-Line Mutation Cell Transformation, Neoplastic Oligonucleotide Array Sequence Analysis RNA, Small Interfering Risk Sensitivity and Specificity Prospective Studies DNA Methylation Epididymal Secretory Proteins Cell Survival Polymerase Chain Reaction Receptor, Epidermal Growth Factor Cancer Vaccines Case-Control Studies Antibodies, Monoclonal Cell Division Receptor, erbB-2

No FAQ available that match "ovarian cancer solid adenocarcinoma"